Bionano Genomics vs Rapid Micro Biosystems
BNGO and RPID side by side, both in laboratory apparatus and analytical, optical, measuring, and controlling instruments. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BNGO and RPID compare
Rapid Micro Biosystems is the larger company, worth 2.7 times as much as Bionano Genomics ($33.7M against $12.2M).
Rapid Micro Biosystems grew revenue faster over the last twelve months (16.1% versus 8.2% for Bionano Genomics).
Bionano Genomics keeps more of each dollar of sales as profit, with a net margin of −96.9% compared with −146% at Rapid Micro Biosystems.
Bionano Genomics scores higher on the StockData Score (12 against 7 for Rapid Micro Biosystems), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BNGO | RPID |
|---|---|---|
| Size and price | ||
| Market cap | $12.2M | $33.7M |
| Share price | $1.04 | $0.671 |
| Change, 1 year | −35.8% | −82.2% |
| Change, 5 years | −100.0% | −95.8% |
| Beta (5Y) | 2.28 | 1.44 |
| Employees | 97 | 171 |
| StockData Score | ||
| Total score | 12 (better) | 7 |
| Valuation score | 3 | 3 |
| Growth score | 3 (better) | 2 |
| Performance score | 1 | 1 |
| Health score | 5 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 0.4× (better) | 1.0× |
| P/B | 0.4× (better) | 1.9× |
| FCF yield | – | −120% |
| Fair value | $5.48 | $1.52 |
| Margin of safety | 81.0% (better) | 55.7% |
| Growth | ||
| Revenue growth (TTM) | 8.2% | 16.1% (better) |
| Revenue growth, 5Y average | 27.4% (better) | 15.9% |
| Profitability | ||
| Gross margin | 48.0% | – |
| Operating margin | −97.1% (better) | −141% |
| Net margin | −96.9% (better) | −146% |
| FCF margin | – | −115% |
| Return on equity | −77.2% (better) | −142% |
| Return on invested capital | −98.8% (better) | −196% |
| Financial health | ||
| Debt / equity | 0.00 | 1.08 (better) |
| Interest coverage | – | −21.2× |
| Current ratio | 2.07 | 2.55 (better) |
| Altman Z-score | −23.17 | −14.30 (better) |
| Piotroski F-score | 6 (better) | 2 |
| Dividends and buybacks | ||
| Buyback yield | −48.4% | – |
| Shareholder yield | −48.4% | 0.00% (better) |
| Ownership | ||
| Held by institutions | 6.0% | 34.9% |
| Held by insiders | 1.8% | 47.2% |
| Insider net buying, 12 months | $9.7K (better) | −$1.1M |
| Short interest, % of float | 12.0% | 2.9% |
Go deeper
- BNGO stock overview
- BNGO income statement
- BNGO valuation and score
- RPID stock overview
- RPID income statement
- RPID valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.